Study of M2A Antigen in Testicular Germ Cell Tumours
Author Information
Author(s): Marks A, Sutherland D R, Bailey D, Iglesias J, Law J, Lei M, Yeger H, Banerjee D, Baumal R
Primary Institution: Banting and Best Department of Medical Research, Departments of Medicine and Pathology, University of Toronto
Hypothesis
M2A antigen is associated with germ cell neoplasia and can be characterized using monoclonal antibodies.
Conclusion
The study found that M2A antigen is present in various types of testicular germ cell tumours and can be detected using specific monoclonal antibodies.
Supporting Evidence
- M2A antigen is present in testis on fetal gonocytes and re-expressed on carcinoma in situ and germ cell tumours.
- The antigen was characterized as a monomeric surface sialoglycoprotein.
- Uniform membrane staining was observed in seminomas.
- Focal staining was found in 69% of embryonal carcinomas, 29% of teratomas, and 25% of yolk sac tumours.
- CIS in the vicinity of all germ cell tumours displayed uniform membrane staining.
Takeaway
Researchers looked at a special protein called M2A in testicular cancer and found it in many cancer types, which helps understand how these cancers grow.
Methodology
The study involved purifying the M2A antigen and using monoclonal antibodies to stain sections of testicular germ cell tumours.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website